Opinion: Pay-to-Play Publishing

Online scientific journals are sacrificing the quality of research articles to make a buck.

Written byKailash Gupta
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© DUSAN PETRICICThe Internet has enabled the dissemination of information at lightning speed. This information revolution has created tremendous business opportunities for online publishers, but not all of them maintain proper quality-control mechanisms to ensure that only good information is being shared. Instead, many publishers aim simply to make money by whatever means possible, with no regard for the ramifications for society at large.

When greedy publishers set up shop online, the primary goal is to publish as much as possible, often at the cost of quality. In this vein, many publishers start numerous online journals focused on overlapping disciplines—to increase their total number of published papers—and hire young business managers who do not have any experience in either science or publishing. In some cases, online publishers even forgo peer review, while still presenting themselves as scientific journals—a scam designed to take advantage of scientists who simply want to share their research. In the most egregious cases, counterfeit publications use the same name as legit journals that are not published online (for example, Archives des Sciences and Wulfenia).

Despite increasing awareness of such “predatory” publishers, these sham journals continue ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies